COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 2681: Articles 26801-26810  | Next

Reduction in stroke patients' referral to the ED in the COVID-19 era: A four-year comparative study
Saban, M., Reznik, A., Shachar, T., Sivan-Hoffmann, R.
10.1101/2020.05.30.20118125 — Posted: 2020-06-03
Continuous positive airway pressure face-mask ventilation to manage massive influx of patients requiring respiratory support during the SARS-CoV-2 outbreak
Alviset, S., Riller, Q., Aboab, J., Dilworth, K., Billy, P. A., Lombardi, Y., Azzi, M., Ferreira Vargas, L., Laine, L., Lermuzeaux, M., Memain, N., Silva, D., Tchoubou, T., Ushmurova, D., Dabbagh, H., Escoda, S., Lefrancois, R., Nardi, A., Ngima, A., IOOS, V.
10.1101/2020.06.01.20118018 — Posted: 2020-06-03
Repurposed prophylaxis strategies for COVID-19: a systematic review
Sallard, E., Lescure, F.-X., Burdet, C., Guedj, J., Yazdanpanah, Y., Peiffer-Smadja, N.
10.1101/2020.05.30.20117937 — Posted: 2020-06-03
A comparative evaluation of dye-based and probe-based RT-qPCR assay for the screening of SARS-CoV-2 using individual and pooled-sample testing.
Verdugo, C., Plaza, A., Acosta-Jamett, G., Castro, N., Gutierrez, J., Hernandez, C., Lopez-Joven, C., Loncoman, C., Navarrete, C., Ramirez-Reveco, A., Romero, A., Silva, A., Vega, M., Verdugo, C., Vergara, J.
10.1101/2020.05.30.20117721 — Posted: 2020-06-03
Cytokine biomarkers of COVID-19
Deng, H.-J., Long, Q.-X., Liu, B.-Z., Ren, J.-H., Liao, P., Qiu, J.-F., Tang, X.-J., Zhang, Y., Tang, N., Xu, Y.-Y., Mo, Z., Chen, J., Hu, J., Huang, A.-L.
10.1101/2020.05.31.20118315 — Posted: 2020-06-03
Evaluating the Efficacy of Stay-At-Home Orders: Does Timing Matter?
Medline, MPH, A., Hayes, L., Vahedi, F., Valdez, K., Sonnenberg, J., Capell, W., Hayashi, A., Klausner, MD, MPH, J. D., Glick, Z.
10.1101/2020.05.30.20117853 — Posted: 2020-06-03
Covid-19 and Population Age Structure
Haridas, A., Pratap, G.
10.1101/2020.05.31.20118349 — Posted: 2020-06-03
Rethinking antiviral effects for COVID-19 in clinical studies: early initiation is key to successful treatment
Iwanami, S., Ejima, K., Kim, K. S., Noshita, K., Fujita, Y., Miyazaki, T., Kohno, S., Miyazaki, Y., Morimoto, S., Nakaoka, S., Koizumi, Y., Asai, Y., Aihara, K., Watashi, K., Thompson, R. N., Shibuya, K., Fujiu, K., Perelson, A. S., Shingo, I., Wakita, T.
10.1101/2020.05.30.20118067 — Posted: 2020-06-03 Discussion: Onsite
Clinical Features and Predictors for Patients with Severe SARS-CoV-2 Pneumonia: a retrospective multicenter cohort study
Cao, C., Chen, M., Li, Y., Yu, L., Huang, W., Qian, G., Zhu, C., Chu, J., He, L., Ma, J., Chen, X.
10.1101/2020.06.01.20119032 — Posted: 2020-06-03
Evaluation of serological tests for SARS-CoV-2: Implications for serology testing in a low-prevalence setting
Bond, K., Nicholson, S., Lim, S., Karapanagiotidis, T., Williams, E., Johnston, D., Hoang, T., Sia, C., Purcell, D., Lewin, S., Catton, M., Howden, B. P., Williamson, D.
10.1101/2020.05.31.20118273 — Posted: 2020-06-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).